RecallRadar

FDA Drug recall D-0362-2022

Metoprolol Tartrate Tablets, USP 25 mg, 1000 - count bottle, Rx Only, Distributed by: TruPharma, LLC. Tampa, FL 33609

On 2022-01-19 the FDA classified a Class II recall of Metoprolol Tartrate Tablets, USP 25 mg, 1000 - count bottle, Rx Only, Distributed by: TruPharma, LLC. Tampa, FL 33609 by Rubicon Research Private, citing complaint received of foreign matter (metal) embedded in tablet.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0362-2022
ClassificationClass II
Statusterminated
Initiated2021-12-31
Published2022-01-19
Last updated2026-09-13 11:52 UTC
CompanyRubicon Research Private
DistributionUS

Product

Metoprolol Tartrate Tablets, USP 25 mg, 1000 - count bottle, Rx Only, Distributed by: TruPharma, LLC. Tampa, FL 33609; Manufactured by: Rubicon Research Prvate Limited Ambernath, Dist. Thane, 421506 India. NDC 52817-360-00

Reason

Complaint received of foreign matter (metal) embedded in tablet.

Identifiers

ndc52817-362-10
ndc52817-362-00
ndc52817-359-10
ndc52817-359-50
ndc52817-361-10
ndc52817-361-00
ndc52817-360-10
ndc52817-360-00
ndc52817-358-10
ndc52817-358-50
code_infoBatch # 210211H1, Exp. date FEB 2024

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0362-2022%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.